WASHINGTON – Amyloid-beta has been the Alzheimer’s research darling for more than a decade, and finally, after many failures, some small successes may be appearing in antiamyloid trials.
Experts...
WASHINGTON – An antiamyloid antibody that showed significant cognitive benefit at 10 mg/kg failed to deliver similar good news at a lower dose in the first randomized, antiamyloid antibody trial...
WASHINGTON – Postoperative cognitive decline, which occurs in roughly 20% of elderly patients who undergo major surgery, strikes older women with greater severity than it does similarly aged men,...
WASHINGTON – Could a ubiquitous lipid – manufactured in the liver – be one of the root causes of Alzheimer’s disease? Plasmalogens are important in maintaining cell membrane permeability and...
The antibiotic dicloxacillin appears to markedly decrease INR levels in patients taking warfarin, reducing the mean INR to subtherapeutic ranges in the majority who take both drugs concomitantly,...
WASHINGTON – Improved management of patients with type 1 diabetes and the resulting increased longevity it has fostered has produced a new medical concern that few patients faced in the past: their...
Black patients with Alzheimer’s disease dementia are much more likely to have an Alzheimer’s pathology mixed with another pathology than are white patients, according to Dr. Lisa Barnes and her...
ROME – There was no advantage to individually prescribed exercises for knee osteoarthritis over usual physiotherapy in a multicenter, longitudinal, randomized study reported at the European Congress...
Viral infections appear to be the primary cause of pneumonia that results in hospitalization, according to a Centers for Disease Control and Prevention study of five urban hospitals in Chicago and...
ROME – Erosive hand osteoarthritis (OA) is probably a more severe form of the disease, rather than a separate clinical entity, a team of Norwegian researchers has suggested.
Dr. Alexander Mathiessen...
